N. Partovi

491 total citations
15 papers, 356 citations indexed

About

N. Partovi is a scholar working on Surgery, Epidemiology and Transplantation. According to data from OpenAlex, N. Partovi has authored 15 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Epidemiology and 4 papers in Transplantation. Recurrent topics in N. Partovi's work include Renal Transplantation Outcomes and Treatments (3 papers), Transplantation: Methods and Outcomes (3 papers) and Organ Transplantation Techniques and Outcomes (3 papers). N. Partovi is often cited by papers focused on Renal Transplantation Outcomes and Treatments (3 papers), Transplantation: Methods and Outcomes (3 papers) and Organ Transplantation Techniques and Outcomes (3 papers). N. Partovi collaborates with scholars based in Canada and United States. N. Partovi's co-authors include Eric M. Yoshida, Ting Liu, Mary H. H. Ensom, Erica D. Greanya, Robert D. Levy, R. Jean Shapiro, Kimberlyn McGrail, Isabella Ghement, Corinne M. Hohl and Maeve E. Wickham and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Transplantation.

In The Last Decade

N. Partovi

14 papers receiving 344 citations

Peers

N. Partovi

EPIDE

TRANS

SURGE

HEPAT

Bertram Hartmann Germany

Binu Mathew India

Steven A. Myre United States

Marilyne Debette‐Gratien France

Harini Sarathy United States

Amanda J. Vinson Canada

GJ Burckart United States

Diane M. Lanese United States

Dena M. Carbonari United States

Ajácio Brandão Brazil

Bertram Hartmann Germany

N. Partovi

126 ×0.8

EPIDE

32 ×0.4

82 ×1.2

TRANS

71 ×1.2

SURGE

72 ×1.4

HEPAT

Citations per year, relative to N. Partovi N. Partovi (= 1×) peers Bertram Hartmann

Countries citing papers authored by N. Partovi

Since Specialization

Citations

This map shows the geographic impact of N. Partovi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Partovi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Partovi more than expected).

Fields of papers citing papers by N. Partovi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Partovi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Partovi. The network helps show where N. Partovi may publish in the future.

Co-authorship network of co-authors of N. Partovi

This figure shows the co-authorship network connecting the top 25 collaborators of N. Partovi. A scholar is included among the top collaborators of N. Partovi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Partovi. N. Partovi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vo, Ashley, N. Partovi, Robert D. Levy, et al.. (2024). Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection. The Journal of Heart and Lung Transplantation. 43(4). S461–S461. 2 indexed citations

Stukas, Sophie, George Goshua, Catherine M. Biggs, et al.. (2022). Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study. The Lancet Regional Health - Americas. 11. 100228–100228. 6 indexed citations

Partovi, N., Rebecca Marsh, Céline Bergeron, et al.. (2022). Therapeutic Drug Monitoring-Guided Combination Alemtuzumab and Plasmapheresis for Refractory Acute Lung Allograft Dysfunction Rescue Therapy. The Journal of Heart and Lung Transplantation. 41(4). S417–S417.

Turgeon, Ricky D., et al.. (2021). Development of a pharmacist-led internal medicine outpatient consult service. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 154(2). 83–86. 1 indexed citations

Partovi, N., et al.. (2020). Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents. Journal of Clinical and Translational Hepatology. 8(3). 1–14. 10 indexed citations

Hussaini, Trana, Eric M. Yoshida, N. Partovi, et al.. (2019). Early Persistent Progressive Acute Kidney Injury and Graft Failure Post Liver Transplantation. Transplantation Direct. 5(3). e429–e429. 9 indexed citations

Levy, Robert D., John Yee, N. Partovi, et al.. (2018). Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report. BMC Pulmonary Medicine. 18(1). 162–162. 9 indexed citations

Hohl, Corinne M., N. Partovi, Isabella Ghement, et al.. (2017). Impact of early in-hospital medication review by clinical pharmacists on health services utilization. PLoS ONE. 12(2). e0170495–e0170495. 51 indexed citations

Partovi, N., et al.. (2012). Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past. Transplant Infectious Disease. 14(5). 519–525. 67 indexed citations

10.

Singham, Janakie, et al.. (2010). Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence†. Annals of Hepatology. 9(2). 166–171. 25 indexed citations

11.

Partovi, N., et al.. (2009). Evaluating Clinical Pharmacy Services In A LEUKEMIA/BMT Medical Intervention Clinic: A Pilot Project. Biology of Blood and Marrow Transplantation. 15(2). 153–153. 2 indexed citations

12.

Partovi, N., et al.. (2008). Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction?. Annals of Pharmacotherapy. 42(7). 1037–1047. 79 indexed citations

13.

Bressler, Brian, et al.. (2008). The Use of Infliximab for Treatment of Hospitalized Patients with Acute Severe Ulcerative Colitis. SHILAP Revista de lepidopterología. 22(11). 937–940. 36 indexed citations

14.

Warnock, Garth L., Mark Meloche, Jerry Shapiro, et al.. (2008). RESULTS OF A MULTI-YEAR COMPARISON OF ISLET TRANSPLANTATION WITH INTENSIVE MEDICAL THERAPY ON THE PROGRESSION OF MICROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES. Transplantation. 86(2S). 85–85. 1 indexed citations

15.

Partovi, N., et al.. (2007). Review article: possible beneficial effects of coffee on liver disease and function. Alimentary Pharmacology & Therapeutics. 26(1). 1–8. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact